<html><head><link rel="stylesheet" type="text/css" href="usc.css"/><title>U.S.C. Title 42 - THE PUBLIC HEALTH AND WELFARE</title></head><body>
<span style="font-weight:bold;font-size:12pt;">42 U.S.C. </span><br/>
<span style="font-size:10pt">United States Code, 2007 Edition</span><br/>
<span style="font-size:10pt">Title 42 - THE PUBLIC HEALTH AND WELFARE</span><br/>
<span style="font-size:10pt">CHAPTER 6A - PUBLIC HEALTH SERVICE</span><br/>
<span style="font-size:10pt">SUBCHAPTER VII - AGENCY FOR HEALTHCARE RESEARCH AND QUALITY</span><br/>
<span style="font-size:10pt">Part A - Establishment and General Duties</span><br/>
<span style="font-size:10pt">From the U.S. Government Printing Office, <a href="http://www.gpo.gov">www.gpo.gov</a></span><br/><br/>
<!-- documentid:42_-ch6A-scVII-Part_A currentthrough:20080108 documentPDFPage:762 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER VII/Part A -->
<!-- itemsortkey:420ABJC -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER VII-AGENCY FOR HEALTHCARE RESEARCH AND QUALITY!@!Part A-Establishment and General Duties -->
<!-- field-start:structuralhead -->
<h3 class="part-head"><cap-smallcap>Part A&mdash;Establishment and General Duties</cap-smallcap></h3>
<!-- field-end:structuralhead -->

<!-- documentid:42_299  usckey:420000000029900000000000000000000 currentthrough:20080108 documentPDFPage:762 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER VII/Part A/Sec. 299 -->
<!-- itemsortkey:420ABJD -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER VII-AGENCY FOR HEALTHCARE RESEARCH AND QUALITY!@!Part A-Establishment and General Duties!@!Sec. 299 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;299. Mission and duties</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) In general</h4>
<p class="statutory-body">There is established within the Public Health Service an agency to be known as the Agency for Healthcare Research and Quality, which shall be headed by a director appointed by the Secretary. The Secretary shall carry out this subchapter acting through the Director.</p>
<h4 class="subsection-head">(b) Mission</h4>
<p class="statutory-body">The purpose of the Agency is to enhance the quality, appropriateness, and effectiveness of health services, and access to such services, through the establishment of a broad base of scientific research and through the promotion of improvements in clinical and health system practices, including the prevention of diseases and other health conditions. The Agency shall promote health care quality improvement by conducting and supporting&mdash;</p>
<p class="statutory-body-1em">(1) research that develops and presents scientific evidence regarding all aspects of health care, including&mdash;</p>
<p class="statutory-body-2em">(A) the development and assessment of methods for enhancing patient participation in their own care and for facilitating shared patient-physician decision-making;</p>
<p class="statutory-body-2em">(B) the outcomes, effectiveness, and cost-effectiveness of health care practices, including preventive measures and long-term care;</p>
<p class="statutory-body-2em">(C) existing and innovative technologies;</p>
<p class="statutory-body-2em">(D) the costs and utilization of, and access to health care;</p>
<p class="statutory-body-2em">(E) the ways in which health care services are organized, delivered, and financed and the interaction and impact of these factors on the quality of patient care;</p>
<p class="statutory-body-2em">(F) methods for measuring quality and strategies for improving quality; and</p>
<p class="statutory-body-2em">(G) ways in which patients, consumers, purchasers, and practitioners acquire new information about best practices and health benefits, the determinants and impact of their use of this information;</p>
<br class="Q04" />
<p class="statutory-body-1em">(2) the synthesis and dissemination of available scientific evidence for use by patients, consumers, practitioners, providers, purchasers, policy makers, and educators; and</p>
<p class="statutory-body-1em">(3) initiatives to advance private and public efforts to improve health care quality.</p>
<h4 class="subsection-head">(c) Requirements with respect to rural and inner-city areas and priority populations</h4>
<h4 class="paragraph-head">(1) Research, evaluations and demonstration projects</h4>
<p class="statutory-body-1em">In carrying out this subchapter, the Director shall conduct and support research and evaluations, and support demonstration projects, with respect to&mdash;</p>
<p class="statutory-body-2em">(A) the delivery of health care in inner-city areas, and in rural areas (including frontier areas); and</p>
<p class="statutory-body-2em">(B) health care for priority populations, which shall include&mdash;</p>
<p class="statutory-body-3em">(i) low-income groups;</p>
<p class="statutory-body-3em">(ii) minority groups;</p>
<p class="statutory-body-3em">(iii) women;</p>
<p class="statutory-body-3em">(iv) children;</p>
<p class="statutory-body-3em">(v) the elderly; and</p>
<p class="statutory-body-3em">(vi) individuals with special health care needs, including individuals with disabilities and individuals who need chronic care or end-of-life health care.</p>
<h4 class="paragraph-head">(2) Process to ensure appropriate research</h4>
<p class="statutory-body-1em">The Director shall establish a process to ensure that the requirements of paragraph (1) are reflected in the overall portfolio of research conducted and supported by the Agency.</p>
<h4 class="paragraph-head">(3) Office of Priority Populations</h4>
<p class="statutory-body-1em">The Director shall establish an Office of Priority Populations to assist in carrying out the requirements of paragraph (1).</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title IX, &sect;901, as added Pub. L. 106&ndash;129, &sect;2(a), Dec. 6, 1999, 113 Stat. 1653.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:priorprovisions-note -->
<h4 class="note-head">Prior Provisions</h4>
<p class="note-body">A prior section 299, act July 1, 1944, ch. 373, title IX, &sect;901, as added Pub. L. 101&ndash;239, title VI, &sect;6103(a), Dec. 19, 1989, 103 Stat. 2189; amended Pub. L. 102&ndash;410, &sect;2(a), Oct. 13, 1992, 106 Stat. 2094, established the Agency for Health Care Policy and Research, prior to the general amendment of this subchapter by Pub. L. 106&ndash;129.</p>
<p class="note-body">Another prior section 299, act July 1, 1944, ch. 373, title IX, &sect;900, as added Oct. 6, 1965, Pub. L. 89&ndash;239, &sect;2, 79 Stat. 926; amended Oct. 30, 1970, Pub. L. 91&ndash;515, title I, &sect;102, 84 Stat. 1297, set forth Congressional declaration of purpose of this subchapter to encourage and assist regional cooperative arrangements among medical schools, research institutions, and hospitals for re<!-- PDFPage:763 -->search, training and medical data exchange, and to improve quality and capacity of health manpower and facilities available throughout the nation, prior to repeal by Pub. L. 99&ndash;117, &sect;12(d), Oct. 7, 1985, 99 Stat. 495.</p>
<p class="note-body">A prior section 901 of act July 1, 1944, was classified to section 299a of this title prior to repeal by Pub. L. 99&ndash;117.</p>
<!-- field-end:priorprovisions-note -->
<!-- field-start:construction-note -->
<h4 class="note-head">Construction</h4>
<p class="note-body">Pub. L. 106&ndash;129, &sect;2(b), Dec. 6, 1999, 113 Stat. 1670, provided that:</p>
<p class="note-body">&ldquo;(1) <cap-smallcap>In general</cap-smallcap>.&mdash;Section 901(a) of the Public Health Service Act [subsec. (a) of this section] (as added by subsection (a) of this section) applies as a redesignation of the agency that carried out title IX of such Act [this subchapter] on the day before the date of the enactment of this Act [Dec. 6, 1999], and not as the termination of such agency and the establishment of a different agency. The amendment made by subsection (a) of this section [enacting this subchapter] does not affect appointments of the personnel of such agency who were employed at the agency on the day before such date, including the appointments of members of advisory councils or study sections of the agency who were serving on the day before such date of enactment.</p>
<p class="note-body">&ldquo;(2) <cap-smallcap>References</cap-smallcap>.&mdash;Any reference in law to the Agency for Health Care Policy and Research is deemed to be a reference to the Agency for Healthcare Research and Quality, and any reference in law to the Administrator for Health Care Policy and Research is deemed to be a reference to the Director of the Agency for Healthcare Research and Quality.&rdquo;</p>
<!-- field-end:construction-note -->
<!-- field-start:savingsprovision-note -->
<h4 class="note-head">Transitional and Savings Provisions</h4>
<p class="note-body">Section 6103(f) of Pub. L. 101&ndash;239 provided that personnel of the Department of Health and Human Services employed, and Department assets used in connection with Department functions, on Dec. 19, 1989, be transferred to the Administrator for Health Care Policy and Research for appropriate allocation, and provided that orders, rules, regulations, grants, contracts, certificates, licenses, privileges, and other determinations, actions, or official documents would continue in effect according to their terms unless changed pursuant to law.</p>
<!-- field-end:savingsprovision-note -->
<!-- field-start:miscellaneous-note -->
<h4 class="note-head">IOM Study on Drug Safety and Quality</h4>
<p class="note-body">Pub. L. 108&ndash;173, title I, &sect;107(c), Dec. 8, 2003, 117 Stat. 2170, provided that:</p>
<p class="note-body">&ldquo;(1) <cap-smallcap>In general</cap-smallcap>.&mdash;The Secretary [of Health and Human Services] shall enter into a contract with the Institutes of Medicine of the National Academies of Science (such Institutes referred to in this subsection as the &lsquo;IOM&rsquo;) to carry out a comprehensive study (in this subsection referred to as the &lsquo;study&rsquo;) of drug safety and quality issues in order to provide a blueprint for system-wide change.</p>
<p class="note-body">&ldquo;(2) <cap-smallcap>Objectives.&mdash;</cap-smallcap></p>
<p class="note-body-1em">&ldquo;(A) The study shall develop a full understanding of drug safety and quality issues through an evidence-based review of literature, case studies, and analysis. This review will consider the nature and causes of medication errors, their impact on patients, the differences in causation, impact, and prevention across multiple dimensions of health care delivery-including patient populations, care settings, clinicians, and institutional cultures.</p>
<p class="note-body-1em">&ldquo;(B) The study shall attempt to develop credible estimates of the incidence, severity, costs of medication errors that can be useful in prioritizing resources for national quality improvement efforts and influencing national health care policy.</p>
<p class="note-body-1em">&ldquo;(C) The study shall evaluate alternative approaches to reducing medication errors in terms of their efficacy, cost-effectiveness, appropriateness in different settings and circumstances, feasibility, institutional barriers to implementation, associated risks, and the quality of evidence supporting the approach.</p>
<p class="note-body-1em">&ldquo;(D) The study shall provide guidance to consumers, providers, payers, and other key stakeholders on high-priority strategies to achieve both short-term and long-term drug safety goals, to elucidate the goals and expected results of such initiatives and support the business case for them, and to identify critical success factors and key levers for achieving success.</p>
<p class="note-body-1em">&ldquo;(E) The study shall assess the opportunities and key impediments to broad nationwide implementation of medication error reductions, and to provide guidance to policy-makers and government agencies (including the Food and Drug Administration, the Centers for Medicare & Medicaid Services, and the National Institutes of Health) in promoting a national agenda for medication error reduction.</p>
<p class="note-body-1em">&ldquo;(F) The study shall develop an applied research agenda to evaluate the health and cost impacts of alternative interventions, and to assess collaborative public and private strategies for implementing the research agenda through AHRQ and other government agencies.</p>
<p class="note-body">&ldquo;(3) <cap-smallcap>Conduct of study.&mdash;</cap-smallcap></p>
<p class="note-body-1em">&ldquo;(A) <cap-smallcap>Expert committee</cap-smallcap>.&mdash;In conducting the study, the IOM shall convene a committee of leading experts and key stakeholders in pharmaceutical management and drug safety, including clinicians, health services researchers, pharmacists, system administrators, payer representatives, and others.</p>
<p class="note-body-1em">&ldquo;(B) <cap-smallcap>Completion</cap-smallcap>.&mdash;The study shall be completed within an 18-month period.</p>
<p class="note-body">&ldquo;(4) <cap-smallcap>Report</cap-smallcap>.&mdash;A report on the study shall be submitted to Congress upon the completion of the study.</p>
<p class="note-body">&ldquo;(5) <cap-smallcap>Authorization of appropriations</cap-smallcap>.&mdash;There are authorized to be appropriated to carry out this section such sums as may be necessary.&rdquo;</p>
<h4 class="note-head">Health Care That Works for All Americans: Citizens Health Care Working Group</h4>
<p class="note-body">Pub. L. 108&ndash;173, title X, &sect;1014, Dec. 8, 2003, 117 Stat. 2441, provided that:</p>
<p class="note-body">&ldquo;(a) <cap-smallcap>Findings</cap-smallcap>.&mdash;Congress finds the following:</p>
<p class="note-body-1em">&ldquo;(1) In order to improve the health care system, the American public must engage in an informed national public debate to make choices about the services they want covered, what health care coverage they want, and how they are willing to pay for coverage.</p>
<p class="note-body-1em">&ldquo;(2) More than a trillion dollars annually is spent on the health care system, yet&mdash;</p>
<p class="note-body-2em">&ldquo;(A) 41,000,000 Americans are uninsured;</p>
<p class="note-body-2em">&ldquo;(B) insured individuals do not always have access to essential, effective services to improve and maintain their health; and</p>
<p class="note-body-2em">&ldquo;(C) employers, who cover over 170,000,000 Americans, find providing coverage increasingly difficult because of rising costs and double digit premium increases.</p>
<p class="note-body-1em">&ldquo;(3) Despite increases in medical care spending that are greater than the rate of inflation, population growth, and Gross Domestic Product growth, there has not been a commensurate improvement in our health status as a nation.</p>
<p class="note-body-1em">&ldquo;(4) Health care costs for even just 1 member of a family can be catastrophic, resulting in medical bills potentially harming the economic stability of the entire family.</p>
<p class="note-body-1em">&ldquo;(5) Common life occurrences can jeopardize the ability of a family to retain private coverage or jeopardize access to public coverage.</p>
<p class="note-body-1em">&ldquo;(6) Innovations in health care access, coverage, and quality of care, including the use of technology, have often come from States, local communities, and private sector organizations, but more creative policies could tap this potential.</p>
<p class="note-body-1em">&ldquo;(7) Despite our Nation's wealth, the health care system does not provide coverage to all Americans who want it.</p>
<p class="note-body">&ldquo;(b) <cap-smallcap>Purposes</cap-smallcap>.&mdash;The purposes of this section are&mdash;</p>
<p class="note-body-1em">&ldquo;(1) to provide for a nationwide public debate about improving the health care system to provide every <!-- PDFPage:764 -->American with the ability to obtain quality, affordable health care coverage; and</p>
<p class="note-body-1em">&ldquo;(2) to provide for a vote by Congress on the recommendations that result from the debate.</p>
<p class="note-body">&ldquo;(c) <cap-smallcap>Establishment</cap-smallcap>.&mdash;The Secretary [of Health and Human Services], acting through the Agency for Healthcare Research and Quality, shall establish an entity to be known as the Citizens&rsquo; Health Care Working Group (referred to in this section as the &lsquo;Working Group&rsquo;).</p>
<p class="note-body">&ldquo;(d) <cap-smallcap>Membership.&mdash;</cap-smallcap></p>
<p class="note-body-1em">&ldquo;(1) <cap-smallcap>Number and appointment</cap-smallcap>.&mdash;The Working Group shall be composed of 15 members. One member shall be the Secretary. The Comptroller General of the United States shall appoint 14 members.</p>
<p class="note-body-1em">&ldquo;(2) <cap-smallcap>Qualifications.&mdash;</cap-smallcap></p>
<p class="note-body-2em">&ldquo;(A) <cap-smallcap>In general</cap-smallcap>.&mdash;The membership of the Working Group shall include&mdash;</p>
<p class="note-body-3em">&ldquo;(i) consumers of health services that represent those individuals who have not had insurance within 2 years of appointment, that have had chronic illnesses, including mental illness, are disabled, and those who receive insurance coverage through medicare and medicaid; and</p>
<p class="note-body-3em">&ldquo;(ii) individuals with expertise in financing and paying for benefits and access to care, business and labor perspectives, and providers of health care.</p>
<p class="note-body-flush0_hang2">&nbsp;&nbsp;The membership shall reflect a broad geographic representation and a balance between urban and rural representatives.</p>
<p class="note-body-2em">&ldquo;(B) <cap-smallcap>Prohibited appointments</cap-smallcap>.&mdash;Members of the Working Group shall not include Members of Congress or other elected government officials (Federal, State, or local). Individuals appointed to the Working Group shall not be paid employees or representatives of associations or advocacy organizations involved in the health care system.</p>
<p class="note-body">&ldquo;(e) <cap-smallcap>Period of Appointment</cap-smallcap>.&mdash;Members of the Working Group shall be appointed for a [sic] life of the Working Group. Any vacancies shall not affect the power and duties of the Working Group but shall be filled in the same manner as the original appointment.</p>
<p class="note-body">&ldquo;(f) <cap-smallcap>Designation of the Chairperson</cap-smallcap>.&mdash;Not later than 15 days after the date on which all members of the Working Group have been appointed under subsection (d)(1), the Comptroller General shall designate the chairperson of the Working Group.</p>
<p class="note-body">&ldquo;(g) <cap-smallcap>Subcommittees</cap-smallcap>.&mdash;The Working Group may establish subcommittees if doing so increases the efficiency of the Working Group in completing its tasks.</p>
<p class="note-body">&ldquo;(h) <cap-smallcap>Duties.&mdash;</cap-smallcap></p>
<p class="note-body-1em">&ldquo;(1) <cap-smallcap>Hearings</cap-smallcap>.&mdash;Not later than 90 days after the date of the designation of the chairperson under subsection (f), the Working Group shall hold hearings to examine&mdash;</p>
<p class="note-body-2em">&ldquo;(A) the capacity of the public and private health care systems to expand coverage options;</p>
<p class="note-body-2em">&ldquo;(B) the cost of health care and the effectiveness of care provided at all stages of disease;</p>
<p class="note-body-2em">&ldquo;(C) innovative State strategies used to expand health care coverage and lower health care costs;</p>
<p class="note-body-2em">&ldquo;(D) local community solutions to accessing health care coverage;</p>
<p class="note-body-2em">&ldquo;(E) efforts to enroll individuals currently eligible for public or private health care coverage;</p>
<p class="note-body-2em">&ldquo;(F) the role of evidence-based medical practices that can be documented as restoring, maintaining, or improving a patient's health, and the use of technology in supporting providers in improving quality of care and lowering costs; and</p>
<p class="note-body-2em">&ldquo;(G) strategies to assist purchasers of health care, including consumers, to become more aware of the impact of costs, and to lower the costs of health care.</p>
<p class="note-body-1em">&ldquo;(2) <cap-smallcap>Additional hearings</cap-smallcap>.&mdash;The Working Group may hold additional hearings on subjects other than those listed in paragraph (1) so long as such hearings are determined to be necessary by the Working Group in carrying out the purposes of this section. Such additional hearings do not have to be completed within the time period specified in paragraph (1) but shall not delay the other activities of the Working Group under this section.</p>
<p class="note-body-1em">&ldquo;(3) <cap-smallcap>The health report to the american people</cap-smallcap>.&mdash;Not later than 90 days after the hearings described in paragraphs (1) and (2) are completed, the Working Group shall prepare and make available to health care consumers through the Internet and other appropriate public channels, a report to be entitled, &lsquo;The Health Report to the American People&rsquo;. Such report shall be understandable to the general public and include&mdash;</p>
<p class="note-body-2em">&ldquo;(A) a summary of&mdash;</p>
<p class="note-body-3em">&ldquo;(i) health care and related services that may be used by individuals throughout their life span;</p>
<p class="note-body-3em">&ldquo;(ii) the cost of health care services and their medical effectiveness in providing better quality of care for different age groups;</p>
<p class="note-body-3em">&ldquo;(iii) the source of coverage and payment, including reimbursement, for health care services;</p>
<p class="note-body-3em">&ldquo;(iv) the reasons people are uninsured or underinsured and the cost to taxpayers, purchasers of health services, and communities when Americans are uninsured or underinsured;</p>
<p class="note-body-3em">&ldquo;(v) the impact on health care outcomes and costs when individuals are treated in all stages of disease;</p>
<p class="note-body-3em">&ldquo;(vi) health care cost containment strategies; and</p>
<p class="note-body-3em">&ldquo;(vii) information on health care needs that need to be addressed;</p>
<p class="note-body-2em">&ldquo;(B) examples of community strategies to provide health care coverage or access;</p>
<p class="note-body-2em">&ldquo;(C) information on geographic-specific issues relating to health care;</p>
<p class="note-body-2em">&ldquo;(D) information concerning the cost of care in different settings, including institutional-based care and home and community-based care;</p>
<p class="note-body-2em">&ldquo;(E) a summary of ways to finance health care coverage; and</p>
<p class="note-body-2em">&ldquo;(F) the role of technology in providing future health care including ways to support the information needs of patients and providers.</p>
<p class="note-body-1em">&ldquo;(4) <cap-smallcap>Community meetings.&mdash;</cap-smallcap></p>
<p class="note-body-2em">&ldquo;(A) <cap-smallcap>In general</cap-smallcap>.&mdash;Not later than 1 year after the date on which all the members of the Working Group have been appointed under subsection (d)(1) and appropriations are first made available to carry out this section, the Working Group shall initiate health care community meetings throughout the United States (in this paragraph referred to as &lsquo;community meetings&rsquo;). Such community meetings may be geographically or regionally based and shall be completed within 180 days after the initiation of the first meeting.</p>
<p class="note-body-2em">&ldquo;(B) <cap-smallcap>Number of meetings</cap-smallcap>.&mdash;The Working Group shall hold a sufficient number of community meetings in order to receive information that reflects&mdash;</p>
<p class="note-body-3em">&ldquo;(i) the geographic differences throughout the United States;</p>
<p class="note-body-3em">&ldquo;(ii) diverse populations; and</p>
<p class="note-body-3em">&ldquo;(iii) a balance among urban and rural populations.</p>
<p class="note-body-2em">&ldquo;(C) <cap-smallcap>Meeting requirements.&mdash;</cap-smallcap></p>
<p class="note-body-3em">&ldquo;(i) <cap-smallcap>Facilitator</cap-smallcap>.&mdash;A State health officer may be the facilitator at the community meetings.</p>
<p class="note-body-3em">&ldquo;(ii) <cap-smallcap>Attendance</cap-smallcap>.&mdash;At least 1 member of the Working Group shall attend and serve as chair of each community meeting. Other members may participate through interactive technology.</p>
<p class="note-body-3em">&ldquo;(iii) <cap-smallcap>Topics</cap-smallcap>.&mdash;The community meetings shall, at a minimum, address the following questions:</p>
<p class="note-body-flush0_hang4">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;(I) What health care benefits and services should be provided?</p>
<p class="note-body-flush0_hang4">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;(II) How does the American public want health care delivered?</p>
<p class="note-body-flush0_hang4">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;(III) How should health care coverage be financed?</p>
<p class="note-body-flush0_hang4">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;(IV) What trade-offs are the American public willing to make in either benefits or financing <!-- PDFPage:765 -->to ensure access to affordable, high quality health care coverage and services?</p>
<p class="note-body-3em">&ldquo;(iv) <cap-smallcap>Interactive technology</cap-smallcap>.&mdash;The Working Group may encourage public participation in community meetings through interactive technology and other means as determined appropriate by the Working Group.</p>
<p class="note-body-2em">&ldquo;(D) <cap-smallcap>Interim requirements</cap-smallcap>.&mdash;Not later than 180 days after the date of completion of the community meetings, the Working Group shall prepare and make available to the public through the Internet and other appropriate public channels, an interim set of recommendations on health care coverage and ways to improve and strengthen the health care system based on the information and preferences expressed at the community meetings. There shall be a 90-day public comment period on such recommendations.</p>
<p class="note-body">&ldquo;(i) <cap-smallcap>Recommendations</cap-smallcap>.&mdash;Not later than 120 days after the expiration of the public comment period described in subsection (h)(4)(D), the Working Group shall submit to Congress and the President a final set of recommendations.</p>
<p class="note-body">&ldquo;(j) <cap-smallcap>Administration.&mdash;</cap-smallcap></p>
<p class="note-body-1em">&ldquo;(1) <cap-smallcap>Executive director</cap-smallcap>.&mdash;There shall be an Executive Director of the Working Group who shall be appointed by the chairperson of the Working Group in consultation with the members of the Working Group.</p>
<p class="note-body-1em">&ldquo;(2) <cap-smallcap>Compensation</cap-smallcap>.&mdash;While serving on the business of the Working Group (including travel time), a member of the Working Group shall be entitled to compensation at the per diem equivalent of the rate provided for level IV of the Executive Schedule under section 5315 of title 5, United States Code, and while so serving away from home and the member's regular place of business, a member may be allowed travel expenses, as authorized by the chairperson of the Working Group. For purposes of pay and employment benefits, rights, and privileges, all personnel of the Working Group shall be treated as if they were employees of the Senate.</p>
<p class="note-body-1em">&ldquo;(3) <cap-smallcap>Information from federal agencies</cap-smallcap>.&mdash;The Working Group may secure directly from any Federal department or agency such information as the Working Group considers necessary to carry out this section. Upon request of the Working Group, the head of such department or agency shall furnish such information.</p>
<p class="note-body-1em">&ldquo;(4) <cap-smallcap>Postal services</cap-smallcap>.&mdash;The Working Group may use the United States mails in the same manner and under the same conditions as other departments and agencies of the Federal Government.</p>
<p class="note-body">&ldquo;(k) <cap-smallcap>Detail</cap-smallcap>.&mdash;Not more than 10 Federal Government employees employed by the Department of Labor and 10 Federal Government employees employed by the Department of Health and Human Services may be detailed to the Working Group under this section without further reimbursement. Any detail of an employee shall be without interruption or loss of civil service status or privilege.</p>
<p class="note-body">&ldquo;(<em>l</em>) <cap-smallcap>Temporary and Intermittent Services</cap-smallcap>.&mdash;The chairperson of the Working Group may procure temporary and intermittent services under section 3109(b) of title 5, United States Code, at rates for individuals which do not exceed the daily equivalent of the annual rate of basic pay prescribed for level V of the Executive Schedule under section 5316 of such title.</p>
<p class="note-body">&ldquo;(m) <cap-smallcap>Annual Report</cap-smallcap>.&mdash;Not later than 1 year after the date of enactment of this Act [Dec. 8, 2003], and annually thereafter during the existence of the Working Group, the Working Group shall report to Congress and make public a detailed description of the expenditures of the Working Group used to carry out its duties under this section.</p>
<p class="note-body">&ldquo;(n) <cap-smallcap>Sunset of Working Group</cap-smallcap>.&mdash;The Working Group shall terminate on the date that is 2 years after the date on which all the members of the Working Group have been appointed under subsection (d)(1) and appropriations are first made available to carry out this section.</p>
<p class="note-body">&ldquo;(<em>o</em>) <cap-smallcap>Administration Review and Comments</cap-smallcap>.&mdash;Not later than 45 days after receiving the final recommendations of the Working Group under subsection (i), the President shall submit a report to Congress which shall contain&mdash;</p>
<p class="note-body-1em">&ldquo;(1) additional views and comments on such recommendations; and</p>
<p class="note-body-1em">&ldquo;(2) recommendations for such legislation and administrative actions as the President considers appropriate.</p>
<p class="note-body">&ldquo;(p) <cap-smallcap>Required Congressional Action</cap-smallcap>.&mdash;Not later than 45 days after receiving the report submitted by the President under subsection (<em>o</em>), each committee of jurisdiction of Congress, the Committee on Finance of the Senate, the Committee on Health, Education, Labor, and Pensions of the Senate, the Committee on Ways and Means of the House of Representatives, the Committee on Energy and Commerce of the House of Representatives, [and the] Committee on Education and the Workforce [now Committee on Education and Labor] of the House of Representatives, shall hold at least 1 hearing on such report and on the final recommendations of the Working Group submitted under subsection (i).</p>
<p class="note-body">&ldquo;(q) <cap-smallcap>Authorization of Appropriations.&mdash;</cap-smallcap></p>
<p class="note-body-1em">&ldquo;(1) <cap-smallcap>In general</cap-smallcap>.&mdash;There are authorized to be appropriated to carry out this section, other than subsection (h)(3), $3,000,000 for each of fiscal years 2005 and 2006.</p>
<p class="note-body-1em">&ldquo;(2) <cap-smallcap>Health report to the american people</cap-smallcap>.&mdash;There are authorized to be appropriated for the preparation and dissemination of the Health Report to the American People described in subsection (h)(3), such sums as may be necessary for the fiscal year in which the report is required to be submitted.&rdquo;</p>
<p class="note-body">[Functions of President under section 1014(<em>o</em>)(1) of Pub. L. 108&ndash;173, set out above, delegated to Secretary of Health and Human Services by Memorandum of President of the United States, Jan. 5, 2007, 72 F.R. 1133.]</p>
<!-- field-end:miscellaneous-note -->
<!-- field-start:executivedocument-note -->
<h4 class="note-head">Executive Order No. 13017</h4>
<p class="note-body">Ex. Ord. No. 13017, Sept. 5, 1996, 61 F.R. 47659, as amended by Ex. Ord. No. 13040, Mar. 25, 1997, 62 F.R. 14773; Ex. Ord. No. 13056, July 21, 1997, 62 F.R. 39415, which established the Advisory Commission on Consumer Protection and Quality in the Health Care Industry, was revoked by Ex. Ord. No. 13138, &sect;3(a), Sept. 30, 1999, 64 F.R. 53880, formerly set out as a note under section 14 of the Federal Advisory Committee Act in the Appendix to Title 5, Government Organization and Employees.</p>
<!-- field-end:executivedocument-note -->
<!-- field-end:notes -->

<!-- documentid:42_299a  usckey:420000000029900000000000a00000000 currentthrough:20080108 documentPDFPage:765 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER VII/Part A/Sec. 299a -->
<!-- itemsortkey:420ABJE -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER VII-AGENCY FOR HEALTHCARE RESEARCH AND QUALITY!@!Part A-Establishment and General Duties!@!Sec. 299a -->
<!-- field-start:head -->
<h3 class="section-head">&sect;299a. General authorities</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) In general</h4>
<p class="statutory-body">In carrying out section 299(b) of this title, the Director shall conduct and support research, evaluations, and training, support demonstration projects, research networks, and multidisciplinary centers, provide technical assistance, and disseminate information on health care and on systems for the delivery of such care, including activities with respect to&mdash;</p>
<p class="statutory-body-1em">(1) the quality, effectiveness, efficiency, appropriateness and value of health care services;</p>
<p class="statutory-body-1em">(2) quality measurement and improvement;</p>
<p class="statutory-body-1em">(3) the outcomes, cost, cost-effectiveness, and use of health care services and access to such services;</p>
<p class="statutory-body-1em">(4) clinical practice, including primary care and practice-oriented research;</p>
<p class="statutory-body-1em">(5) health care technologies, facilities, and equipment;</p>
<p class="statutory-body-1em">(6) health care costs, productivity, organization, and market forces;</p>
<p class="statutory-body-1em">(7) health promotion and disease prevention, including clinical preventive services;</p>
<!-- PDFPage:766 --><p class="statutory-body-1em">(8) health statistics, surveys, database development, and epidemiology; and</p>
<p class="statutory-body-1em">(9) medical liability.</p>
<h4 class="subsection-head">(b) Health services training grants</h4>
<h4 class="paragraph-head">(1) In general</h4>
<p class="statutory-body-1em">The Director may provide training grants in the field of health services research related to activities authorized under subsection (a) of this section, to include pre- and post-doctoral fellowships and training programs, young investigator awards, and other programs and activities as appropriate. In carrying out this subsection, the Director shall make use of funds made available under section 288(d)(3) of this title as well as other appropriated funds.</p>
<h4 class="paragraph-head">(2) Requirements</h4>
<p class="statutory-body-1em">In developing priorities for the allocation of training funds under this subsection, the Director shall take into consideration shortages in the number of trained researchers who are addressing health care issues for the priority populations identified in section 299(c)(1)(B) of this title and in addition, shall take into consideration indications of long-term commitment, amongst applicants for training funds, to addressing health care needs of the priority populations.</p>
<h4 class="subsection-head">(c) Multidisciplinary centers</h4>
<p class="statutory-body">The Director may provide financial assistance to assist in meeting the costs of planning and establishing new centers, and operating existing and new centers, for multidisciplinary health services research, demonstration projects, evaluations, training, and policy analysis with respect to the matters referred to in subsection (a) of this section.</p>
<h4 class="subsection-head">(d) Relation to certain authorities regarding social security</h4>
<p class="statutory-body">Activities authorized in this section shall be appropriately coordinated with experiments, demonstration projects, and other related activities authorized by the Social Security Act [42 U.S.C. 301 et seq.] and the Social Security Amendments of 1967. Activities under subsection (a)(2) of this section that affect the programs under titles XVIII, XIX and XXI of the Social Security Act [42 U.S.C. 1395 et seq., 1396 et seq., 1397aa et seq.] shall be carried out consistent with section 1142 of such Act [42 U.S.C. 1320b&ndash;12].</p>
<h4 class="subsection-head">(e) Disclaimer</h4>
<p class="statutory-body">The Agency shall not mandate national standards of clinical practice or quality health care standards. Recommendations resulting from projects funded and published by the Agency shall include a corresponding disclaimer.</p>
<h4 class="subsection-head">(f) Rule of construction</h4>
<p class="statutory-body">Nothing in this section shall be construed to imply that the Agency's role is to mandate a national standard or specific approach to quality measurement and reporting. In research and quality improvement activities, the Agency shall consider a wide range of choices, providers, health care delivery systems, and individual preferences.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title IX, &sect;902, as added Pub. L. 106&ndash;129, &sect;2(a), Dec. 6, 1999, 113 Stat. 1654; amended Pub. L. 106&ndash;525, title II, &sect;201(a)(1), Nov. 22, 2000, 114 Stat. 2505.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:referenceintext-note -->
<h4 class="note-head">References in Text</h4>
<p class="note-body">The Social Security Act, referred to in subsec. (d), is act Aug. 14, 1935, ch. 531, 49 Stat. 620, as amended, which is classified generally to chapter 7 (&sect;301 et seq.) of this title. Titles XVIII, XIX, and XXI of the Act are classified generally to subchapters XVIII (&sect;1395 et seq.), XIX (&sect;1396 et seq.), and XXI (&sect;1397aa et seq.) of chapter 7 of this title. For complete classification of this Act to the Code, see section 1305 of this title and Tables.</p>
<p class="note-body">The Social Security Amendments of 1967, referred to in subsec. (d), is Pub. L. 90&ndash;248, Jan. 2, 1968, 81 Stat. 821, as amended. For complete classification of this Act to the Code, see Short Title of 1968 Amendment note set out under section 1305 of this title and Tables.</p>
<!-- field-end:referenceintext-note -->
<!-- field-start:priorprovisions-note -->
<h4 class="note-head">Prior Provisions</h4>
<p class="note-body">A prior section 299a, act July 1, 1944, ch. 373, title IX, &sect;902, as added Pub. L. 101&ndash;239, title VI, &sect;6103(a), Dec. 19, 1989, 103 Stat. 2189; amended Pub. L. 101&ndash;639, &sect;3(d), Nov. 28, 1990, 104 Stat. 4603; Pub. L. 102&ndash;410, &sect;2(b), Oct. 13, 1992, 106 Stat. 2094, required Administrator to conduct and support research, demonstration projects, evaluations, training, guideline development, and dissemination of information on health care services and on systems for delivery of such services, prior to the general amendment of this subchapter by Pub. L. 106&ndash;129.</p>
<p class="note-body">Another prior section 299a, act July 1, 1944, ch. 373, title IX, &sect;901, as added Oct. 6, 1965, Pub. L. 89&ndash;239, &sect;2, 79 Stat. 926; amended Oct. 15, 1968, Pub. L. 90&ndash;574, title I, &sect;&sect;101, 102, 107, 82 Stat. 1005, 1006; June 30, 1970, Pub. L. 91&ndash;296, title IV, &sect;401(b)(1)(F), 84 Stat. 352; Oct. 30, 1970, Pub. L. 91&ndash;515, title I, &sect;103, 84 Stat. 1298; June 18, 1973, Pub. L. 93&ndash;45, title I, &sect;110, 87 Stat. 93, authorized appropriations for grants and contracts to carry out purposes of this subchapter and set forth extent of and limitations on grants, prior to repeal by Pub. L. 99&ndash;117, &sect;12(d), Oct. 7, 1985, 99 Stat. 495.</p>
<p class="note-body">A prior section 902 of act July 1, 1944, was classified to section 299b of this title prior to repeal by Pub. L. 99&ndash;117.</p>
<!-- field-end:priorprovisions-note -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">2000&mdash;Subsec. (g). Pub. L. 106&ndash;525 struck out heading and text of subsec. (g). Text read as follows: &ldquo;Beginning with fiscal year 2003, the Director shall annually submit to the Congress a report regarding prevailing disparities in health care delivery as it relates to racial factors and socioeconomic factors in priority populations.&rdquo;</p>
<!-- field-end:amendment-note -->
<!-- field-start:miscellaneous-note -->
<h4 class="note-head">Reducing Administrative Health Care Costs</h4>
<p class="note-body">Pub. L. 103&ndash;43, title XIX, &sect;1909, June 10, 1993, 107 Stat. 205, as amended by Pub. L. 106&ndash;129, &sect;2(b)(2), Dec. 6, 1999, 113 Stat. 1670; Pub. L. 108&ndash;173, title IX, &sect;900(e)(6)(F), Dec. 8, 2003, 117 Stat. 2374, provided that: &ldquo;The Secretary of Health and Human Services, acting through the Agency for Healthcare Research and Quality and, to the extent possible, in consultation with the Centers for Medicare & Medicaid Services, may fund research to develop a text-based standardized billing process, through the utilization of text-based information retrieval and natural language processing techniques applied to automatic coding and analysis of textual patient discharge summaries and other text-based electronic medical records, within a parallel general purpose (shared memory) high performance computing environment. The Secretary shall determine whether such a standardized approach to medical billing, through the utilization of the text-based hospital discharge summary as well as electronic patient records can reduce the administrative billing costs of health care delivery.&rdquo;</p>
<!-- field-end:miscellaneous-note -->
<!-- field-end:notes -->

<!-- documentid:42_299a-1  usckey:420000000029900000000000a00010000 currentthrough:20080108 documentPDFPage:766 -->
<!-- itempath:/420/CHAPTER 6A/SUBCHAPTER VII/Part A/Sec. 299a-1 -->
<!-- itemsortkey:420ABJF -->
<!-- expcite:TITLE 42-THE PUBLIC HEALTH AND WELFARE!@!CHAPTER 6A-PUBLIC HEALTH SERVICE!@!SUBCHAPTER VII-AGENCY FOR HEALTHCARE RESEARCH AND QUALITY!@!Part A-Establishment and General Duties!@!Sec. 299a-1 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;299a&ndash;1. Research on health disparities</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) In general</h4>
<p class="statutory-body">The Director shall&mdash;</p>
<!-- PDFPage:767 --><p class="statutory-body-1em">(1) conduct and support research to identify populations for which there is a significant disparity in the quality, outcomes, cost, or use of health care services or access to and satisfaction with such services, as compared to the general population;</p>
<p class="statutory-body-1em">(2) conduct and support research on the causes of and barriers to reducing the health disparities identified in paragraph (1), taking into account such factors as socioeconomic status, attitudes toward health, the language spoken, the extent of formal education, the area or community in which the population resides, and other factors the Director determines to be appropriate;</p>
<p class="statutory-body-1em">(3) conduct and support research and support demonstration projects to identify, test, and evaluate strategies for reducing or eliminating health disparities, including development or identification of effective service delivery models, and disseminate effective strategies and models;</p>
<p class="statutory-body-1em">(4) develop measures and tools for the assessment and improvement of the outcomes, quality, and appropriateness of health care services provided to health disparity populations;</p>
<p class="statutory-body-1em">(5) in carrying out section 299a(c) of this title, provide support to increase the number of researchers who are members of health disparity populations, and the health services research capacity of institutions that train such researchers; and</p>
<p class="statutory-body-1em">(6) beginning with fiscal year 2003, annually submit to the Congress a report regarding prevailing disparities in health care delivery as it relates to racial factors and socioeconomic factors in priority populations.</p>
<h4 class="subsection-head">(b) Research and demonstration projects</h4>
<h4 class="paragraph-head">(1) In general</h4>
<p class="statutory-body-1em">In carrying out subsection (a) of this section, the Director shall conduct and support research and support demonstrations to&mdash;</p>
<p class="statutory-body-2em">(A) identify the clinical, cultural, socioeconomic, geographic, and organizational factors that contribute to health disparities, including minority health disparity populations, which research shall include behavioral research, such as examination of patterns of clinical decisionmaking, and research on access, outreach, and the availability of related support services (such as cultural and linguistic services);</p>
<p class="statutory-body-2em">(B) identify and evaluate clinical and organizational strategies to improve the quality, outcomes, and access to care for health disparity populations, including minority health disparity populations;</p>
<p class="statutory-body-2em">(C) test such strategies and widely disseminate those strategies for which there is scientific evidence of effectiveness; and</p>
<p class="statutory-body-2em">(D) determine the most effective approaches for disseminating research findings to health disparity populations, including minority populations.</p>
<h4 class="paragraph-head">(2) Use of certain strategies</h4>
<p class="statutory-body-1em">In carrying out this section, the Director shall implement research strategies and mechanisms that will enhance the involvement of individuals who are members of minority health disparity populations or other health disparity populations, health services researchers who are such individuals, institutions that train such individuals as researchers, members of minority health disparity populations or other health disparity populations for whom the Agency is attempting to improve the quality and outcomes of care, and representatives of appropriate tribal or other community-based organizations with respect to health disparity populations. Such research strategies and mechanisms may include the use of&mdash;</p>
<p class="statutory-body-2em">(A) centers of excellence that can demonstrate, either individually or through consortia, a combination of multi-disciplinary expertise in outcomes or quality improvement research, linkages to relevant sites of care, and a demonstrated capacity to involve members and communities of health disparity populations, including minority health disparity populations, in the planning, conduct, dissemination, and translation of research;</p>
<p class="statutory-body-2em">(B) provider-based research networks, including health plans, facilities, or delivery system sites of care (especially primary care), that make extensive use of health care providers who are members of health disparity populations or who serve patients in such populations and have the capacity to evaluate and promote quality improvement;</p>
<p class="statutory-body-2em">(C) service delivery models (such as health centers under section 254b of this title and the Indian Health Service) to reduce health disparities; and</p>
<p class="statutory-body-2em">(D) innovative mechanisms or strategies that will facilitate the translation of past research investments into clinical practices that can reasonably be expected to benefit these populations.</p>
<h4 class="subsection-head">(c) Quality measurement development</h4>
<h4 class="paragraph-head">(1) In general</h4>
<p class="statutory-body-1em">To ensure that health disparity populations, including minority health disparity populations, benefit from the progress made in the ability of individuals to measure the quality of health care delivery, the Director shall support the development of quality of health care measures that assess the experience of such populations with health care systems, such as measures that assess the access of such populations to health care, the cultural competence of the care provided, the quality of the care provided, the outcomes of care, or other aspects of health care practice that the Director determines to be important.</p>
<h4 class="paragraph-head">(2) Examination of certain practices</h4>
<p class="statutory-body-1em">The Director shall examine the practices of providers that have a record of reducing health disparities or have experience in providing culturally competent health services to minority health disparity populations or other health disparity populations. In examining such practices of providers funded under the authorities of this chapter, the Director shall consult with the heads of the relevant agencies of the Public Health Service.</p>
<!-- PDFPage:768 --><h4 class="paragraph-head">(3) Report</h4>
<p class="statutory-body-1em">Not later than 36 months after November 22, 2000, the Secretary, acting through the Director, shall prepare and submit to the appropriate committees of Congress a report describing the state-of-the-art of quality measurement for minority and other health disparity populations that will identify critical unmet needs, the current activities of the Department to address those needs, and a description of related activities in the private sector.</p>
<h4 class="subsection-head">(d) Definition</h4>
<p class="statutory-body">For purposes of this section:</p>
<p class="statutory-body-1em">(1) The term &ldquo;health disparity population&rdquo; has the meaning given such term in section 287c&ndash;31 of this title, except that in addition to the meaning so given, the Director may determine that such term includes populations for which there is a significant disparity in the quality, outcomes, cost, or use of health care services or access to or satisfaction with such services as compared to the general population.</p>
<p class="statutory-body-1em">(2) The term &ldquo;minority&rdquo;, with respect to populations, refers to racial and ethnic minority groups as defined in section 300u&ndash;6 of this title.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(July 1, 1944, ch. 373, title IX, &sect;903, as added Pub. L. 106&ndash;525, title II, &sect;201(a)(2), Nov. 22, 2000, 114 Stat. 2505.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:priorprovisions-note -->
<h4 class="note-head">Prior Provisions</h4>
<p class="note-body">A prior section 299a&ndash;1, act July 1, 1944, ch. 373, title IX, &sect;903, as added Pub. L. 101&ndash;239, title VI, &sect;6103(a), Dec. 19, 1989, 103 Stat. 2190; amended Pub. L. 102&ndash;410, &sect;3, Oct. 13, 1992, 106 Stat. 2094; Pub. L. 103&ndash;43, title XIV, &sect;1422(a), June 10, 1993, 107 Stat. 172, related to public dissemination of information about studies and projects prior to the general amendment of this subchapter by Pub. L. 106&ndash;129. See section 299c&ndash;3 of this title.</p>
<p class="note-body">A prior section 903 of act July 1, 1944, was classified to section 299c of this title prior to repeal by Pub. L. 99&ndash;117.</p>
<p class="note-body">Prior sections 299a&ndash;2 and 299a&ndash;3 were omitted in the general amendment of this subchapter by Pub. L. 106&ndash;129.</p>
<p class="note-body">Section 299a&ndash;2, act July 1, 1944, ch. 373, title IX, &sect;904, as added Pub. L. 101&ndash;239, title VI, &sect;6103(a), Dec. 19, 1989, 103 Stat. 2191; amended Pub. L. 102&ndash;410, &sect;4(a), Oct. 13, 1992, 106 Stat. 2095; Pub. L. 103&ndash;43, title XX, &sect;2013(1), June 10, 1993, 107 Stat. 214, related to health care technology assessment. See section 299b&ndash;5 of this title.</p>
<p class="note-body">Section 299a&ndash;3, act July 1, 1944, ch. 373, title IX, &sect;905, as added Pub. L. 105&ndash;115, title IV, &sect;409, Nov. 21, 1997, 111 Stat. 2371, established demonstration program regarding centers for education and research on therapeutics. See section 299b&ndash;1(b) of this title.</p>
<!-- field-end:priorprovisions-note -->
<!-- field-end:notes -->


</body></html>